ALBT (Avalon GloboCare Corporation) Total Net Assets

Public company logo of Avalon GloboCare Corp (ALBT)

Avalon GloboCare (ALBT) provides cellular diagnostics and laboratory research services. The company's price chart visualizes scaling potential via a cloud-based AI service that processes genetics without increasing headcount, with the metric standing at -0.03. Standard tests currently generate revenue, while medium-term growth is expected from oncology therapies. Business success relies on digital health monitoring and a strategic alliance with medical centers.

ALBT (Avalon GloboCare Corp.) Company Book Value history from 04/28/2023 to 07/22/2026

Avalon GloboCare Corporation - analytical breakdowns and key metrics (ALBT)

- share price and expert price forecast:
Price Chart Avalon GloboCare|ALBT - Consensus Target
- business market valuation indicators:
Market Value Avalon GloboCare Corp|ALBT - Real Price to Acquire Entire Company
- business book valuation details:
Book Price of a Share Avalon GloboCare|ALBT - Company Book Value|Market Value to Book Value avalon-globocare.com|ALBT - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital Avalon GloboCare|ALBT - Long-Term Debt to Capital|Short-Term Debt to Capital Avalon GloboCare|ALBT - Company Total Debt|Debt to Book Capital Avalon GloboCare Corp|ALBT - Company Long-Term Debt|Company Current Liabilities Avalon GloboCare|Immediate Liquidity avalon-globocare.com
- net income and valuation multiples indicators:
ALBT - Company Net Income
Fundamental valuation:Avalon GloboCare Corp. (ALBT)
Core merchandise of Avalon GloboCare Corporation

For a fundamental valuation of Avalon GloboCare (ALBT), analyzing equity dynamics is critical, as it reflects the real value of net assets minus liabilities. The company's total book capitalization allows for the tracking of daily liquidity and the funding stability of healthcare ESG initiatives, confirming the issuer's ability to invest in energy-efficient IT platforms without the risk of debt overload or capital drawdown.

Competitor analysis

HCA: Company Book Value|THC (Tenet Healthcare) - Company Net Assets|FMS: Total Net Assets|Company Net Assets SOLV|EHC (Encompass Health Corp) - Total Net Assets|Company Book Value Universal Health Services (UHS)|DVA (DaVita Corp) - Accounting Value of Company|Book Capitalization RDNT (RadNet, Inc.)|optioncarehealth.com (OPCH) - Total Stockholders' Equity|Surgery Partners - Book Capitalization|PINC - Book Capitalization|EYE (National Vision Corp) - Company Net Assets|PGNY: Total Net Assets|Company Book Value Ardent Health Partners, Inc.|Company Net Assets selectmedical.com (SEM)|Book Capitalization ASTH|MD - Total Stockholders' Equity|Company Book Value U.S. Physical Therapy, Inc. USPH|PNTG: Accounting Capitalization|ORGO: Company Net Assets|nutexhealth.com - Total Net Assets|AUNA: Book Capitalization|SBC Medical Group Inc (SBC) - Book Capitalization|Company Net Assets EOLS|Company Book Value CYH|Book Capitalization SKIN|Book Capitalization mediwound.com (MDWD)|Company Book Value biote Corp BTMD|The Joint Corp - Company Book Value|DCGO - Company Book Value|Total Stockholders' Equity P3 Health Partners Inc.|Gain Therapeutics, Inc. (GANX) - Company Book Value|Accounting Capitalization EUDA|Company Net Assets BMGL|CLGN: Accounting Value of Company|Book Capitalization CUPR|Concord Medical Corp (CCM) - Book Value of Business|Company Book Value American Shared Hospital AMS|medirom.co.jp - Company Book Value|DHAI - Company Book Value|Total Stockholders' Equity Carmell Therapeutics Corporation|NIVF: Book Capitalization|ATIP (ATI Physical Therapy, Inc.) - Company Book Value|Company Book Value CareMax, Inc.|Total Stockholders' Equity kindlymd.com KDLY|Book Capitalization MODV|Company Net Assets Novo Integrated Sciences Inc NVOS|Book Capitalization SSY (SunLink Health Systems, Inc.)|Book Capitalization IMAC Corp BACK